IDH-wildtype glioblastoma
MONDO:0850335A glioblastoma that is characterized by high cellularity, high mitotic activity, necrosis or microvascular proliferation and that lacks mutations in IDH genes.
2898 clinical trials for this condition and its sub-types, 82 tagged with IDH-wildtype glioblastoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New light therapy for brain cancer shows promise in early trial
Disease control Stopped earlyThis trial tested a light-activated drug called PD L 506 (5-aminolevulinic acid) in 17 adults with a type of aggressive brain tumor called glioblastoma that could not be fully removed by surgery. The drug is given by mouth and then activated by a laser inserted into the brain to …
Phase 2 • Sponsor: photonamic GmbH & Co. KG • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental drug aims to supercharge radiation against glioblastoma
Disease control Stopped earlyThis Phase 2 trial tested a drug called ropidoxuridine, taken as a pill, to see if it could make radiation therapy more effective for people with a newly diagnosed, aggressive type of brain cancer (glioblastoma). The study enrolled 30 patients with a specific genetic marker (unme…
Phase 2 • Sponsor: Shuttle Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC